Caligan Partners LP
CIK 1727492 · last filed 2025-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$636.61M
Companies
4
Total Filings
15
Lifetime Open-Market Net
$15.85M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EXEL | Director | 928,906 | $53.13 | $49.35M | $0 | 2 | 2025-06-02 |
| LQDA | Director | 8,138,951 | $71.23 | $579.74M | $5.95M | 6 | 2024-09-12 |
| LAB | 10%+ Owner | 8,467,920 | $0.89 | $7.52M | $9.90M | 6 | 2023-07-03 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2020-11-17 |
Recent Filings · Page 2 of 2
15 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-19 | LQDA | Buy (P) | +442,208 | $2.60M | EDGAR |
| 2022-05-10 | LAB | Buy (P) | +976,700 | $2.81M | EDGAR |
| 2022-04-13 | LAB | Buy (P) | +390,000 | $1.48M | EDGAR |
| 2022-04-08 | LAB | Buy (P) | +1,019,146 | $3.84M | EDGAR |
| 2020-11-17 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Disp (D) | −3,499,428 | $0 | EDGAR |
Showing 11–15 of 15
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.